Frequency of detection and factors of elevated levels of diabetes-associated autoantibodies in the blood of patients with clinical type 2 diabetes mellitus
Background. Some patients with clinical course of type 2 diabetes mellitus (T2DM) exhibit signs of an autoimmune process, particularly an elevated level of glutamic acid decarboxylase autoantibodies (GADA), indicating an autoimmune component of the disease. Patients with GADA-positive T2DM have a d...
Saved in:
Main Authors: | Y.A. Saienko, B.M. Mankovsky |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaslavsky O.Yu.
2025-04-01
|
Series: | Mìžnarodnij Endokrinologìčnij Žurnal |
Subjects: | |
Online Access: | https://iej.zaslavsky.com.ua/index.php/journal/article/view/1512 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IMMUNOLOGICAL MARKERS OF DIABETES MELLITUS IN VARIOUS CLINICAL VARIANTS OF THE DISORDER
by: G. G. Baiburina
Published: (2014-07-01) -
Monocyte chemoattractant protein-1 in patients with different types of diabetes mellitus: clinical and practical significance
by: Ivan I. Golodnikov, et al.
Published: (2025-01-01) -
Autoantibodies to neural receptors in children with type 1 diabetes mellitus
by: Yu. V. Bykov, et al.
Published: (2023-08-01) -
Hybrid diabetes in a patient with latent autoimmune diabetes in adults and genetic markers of predisposition to type 2 diabetes and obesity. Сlinical observation
by: A. V. Vetrova, et al.
Published: (2023-04-01) -
The role of cytokines in the pathogenesis of autoimmune diabetes, immune intervention issues
by: Ye. B. Kravets, et al.
Published: (2010-02-01)